DANA-FARBER CANCER INSTITUTE
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1947-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.dana-farber.org/
Pilot Randomized Controlled Trial of a Collaborative Agenda-setting Intervention (CASI) for Patients With Ovarian Cancer
Not Applicable
Recruiting
- Conditions
- Ovarian CarcinomaOvarian CancerOvarian Neoplasms
- Interventions
- Behavioral: Collaborative Agenda-Setting Intervention
- First Posted Date
- 2024-08-09
- Last Posted Date
- 2025-01-29
- Lead Sponsor
- Dana-Farber Cancer Institute
- Target Recruit Count
- 112
- Registration Number
- NCT06543537
- Locations
- 🇺🇸
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
Evaluation of Multi-Cancer Early Detection Testing in a High-Risk Military Population: The Sentinel Study
Not Applicable
Recruiting
- Conditions
- Cancer Diagnosis
- Interventions
- Other: GRAIL Galleri
- First Posted Date
- 2024-07-26
- Last Posted Date
- 2025-04-10
- Lead Sponsor
- Dana-Farber Cancer Institute
- Target Recruit Count
- 1500
- Registration Number
- NCT06523868
- Locations
- 🇺🇸
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
The COMPASSION Study
Not Applicable
Recruiting
- Conditions
- Breast CancerAdvanced Breast CancerMetastatic Breast CancerUnresectable Breast Carcinoma
- Interventions
- Other: Telehealth Hospice Visits
- First Posted Date
- 2024-07-18
- Last Posted Date
- 2025-02-27
- Lead Sponsor
- Dana-Farber Cancer Institute
- Target Recruit Count
- 200
- Registration Number
- NCT06507930
- Locations
- 🇺🇸
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
PRISM for Depression and Anxiety in Young Adults With Cancer
Not Applicable
Recruiting
- Conditions
- Cancer DiagnosisNon-Metastatic NeoplasmAnxietyAnxiety DisordersDepressionDepressive DisorderDepression, AnxietyDesmoid
- Interventions
- Behavioral: Promoting Resilience in Stress Management Program
- First Posted Date
- 2024-07-16
- Last Posted Date
- 2025-01-31
- Lead Sponsor
- Dana-Farber Cancer Institute
- Target Recruit Count
- 15
- Registration Number
- NCT06502483
- Locations
- 🇺🇸
Dana-Farber Cancer Institute, Brighton, Massachusetts, United States
HEME Home Transfusion Program
Not Applicable
Not yet recruiting
- Conditions
- MyelomaLeukemiaMyelodysplastic SyndromesHematologic DiseasesHematologic MalignancyLymphoma
- Interventions
- Behavioral: HEME-Hospice Program
- First Posted Date
- 2024-07-05
- Last Posted Date
- 2025-01-31
- Lead Sponsor
- Dana-Farber Cancer Institute
- Target Recruit Count
- 700
- Registration Number
- NCT06487247
- Locations
- 🇺🇸
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸Brigham and Women's Hospital, Boston, Massachusetts, United States
Phase Ib Study of Axatilimab in Combination With Olaparib in BRCA1/2 and PALB2- Associated Metastatic HER2-negative Breast Cancer
Phase 1
Recruiting
- Conditions
- BRCA1 MutationBreast CancerHER2-negative Breast CancerBRCA2 MutationPALB2-Mutated Breast Carcinoma
- First Posted Date
- 2024-07-05
- Last Posted Date
- 2024-08-23
- Lead Sponsor
- Dana-Farber Cancer Institute
- Target Recruit Count
- 20
- Registration Number
- NCT06488378
Pembrolizumab + Chemotherapy in Newly Diagnosed PCNSL
Phase 1
Recruiting
- Conditions
- Primary Central Nervous System LymphomaLymphoma
- Interventions
- First Posted Date
- 2024-06-26
- Last Posted Date
- 2025-05-22
- Lead Sponsor
- Dana-Farber Cancer Institute
- Target Recruit Count
- 15
- Registration Number
- NCT06475235
- Locations
- 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
🇺🇸Dana Farber Cancer Institute, Boston, Massachusetts, United States
Developing Restful Environments and Management Strategies for Pediatric Stem Cell Transplant Patients
Not Applicable
Not yet recruiting
- Conditions
- Sleep DisturbanceStem Cell Transplant Complications
- Interventions
- Behavioral: DREAMS Program Video and Care Kit
- First Posted Date
- 2024-06-21
- Last Posted Date
- 2024-07-15
- Lead Sponsor
- Dana-Farber Cancer Institute
- Target Recruit Count
- 10
- Registration Number
- NCT06468618
- Locations
- 🇺🇸
Boston Children's Hospital, Boston, Massachusetts, United States
🇺🇸Dana-Farber Cancer Institute, Boston, Massachusetts, United States
Driving Inclusivity, Validity, and Equity in Research Through Strategic Engagement (DIVERSE)
Recruiting
- Conditions
- LeukemiaBlood Cancer
- Interventions
- Other: DIVERSE Review Process
- First Posted Date
- 2024-06-21
- Last Posted Date
- 2025-05-19
- Lead Sponsor
- Dana-Farber Cancer Institute
- Target Recruit Count
- 40
- Registration Number
- NCT06469307
- Locations
- 🇺🇸
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
Sexual Health and Rehabilitation Online (SHAREonline)
Not Applicable
Recruiting
- Conditions
- Cancer SurvivorshipSexual Function Disturbances
- Interventions
- Behavioral: Educational MaterialsBehavioral: Group SessionBehavioral: Coaching Call
- First Posted Date
- 2024-06-13
- Last Posted Date
- 2025-02-21
- Lead Sponsor
- Dana-Farber Cancer Institute
- Target Recruit Count
- 84
- Registration Number
- NCT06458049
- Locations
- 🇺🇸
Dana Farber Cancer Institute, Boston, Massachusetts, United States
© Copyright 2025. All Rights Reserved by MedPath